Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus.

PubWeight™: 6.39‹?› | Rank: Top 1%

🔗 View Article (PMID 10404017)

Published in J Bone Miner Res on July 01, 1999

Authors

T Hildebrand1, A Laib, R Müller, J Dequeker, P Rüegsegger

Author Affiliations

1: Institute for Biomedical Engineering, University of Zürich and Swiss Federal Institute of Technology (ETH), Zürich, Switzerland.

Articles citing this

(truncated to the top 100)

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest (2012) 4.31

BoneJ: Free and extensible bone image analysis in ImageJ. Bone (2010) 3.91

Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest (2002) 3.86

Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11

Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res (2010) 2.39

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32

Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res (2005) 2.04

High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01

Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A (2006) 1.95

Hyponatremia-induced osteoporosis. J Bone Miner Res (2010) 1.95

Complete volumetric decomposition of individual trabecular plates and rods and its morphological correlations with anisotropic elastic moduli in human trabecular bone. J Bone Miner Res (2008) 1.89

Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88

Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74

Bone densitometry is not a good predictor of hip fracture. BMJ (2001) 1.67

Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med (2002) 1.67

Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol (2009) 1.64

Botox induced muscle paralysis rapidly degrades bone. Bone (2005) 1.63

Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2009) 1.61

Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One (2008) 1.60

Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet (2006) 1.56

A biomechanical perspective on bone quality. Bone (2006) 1.53

Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52

In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol. J Bone Miner Res (2008) 1.45

Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone (2007) 1.43

Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study. J Bone Miner Res (2005) 1.42

In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res (2008) 1.40

beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J Bone Miner Res (2004) 1.39

Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res (2012) 1.37

Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci U S A (2008) 1.34

High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res (2011) 1.32

Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci U S A (2004) 1.32

Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol (2005) 1.30

SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin. EMBO Mol Med (2013) 1.30

Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci (2009) 1.29

Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther (2009) 1.28

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26

Aged mice have enhanced endocortical response and normal periosteal response compared with young-adult mice following 1 week of axial tibial compression. J Bone Miner Res (2010) 1.25

Volumetric topological analysis: a novel approach for trabecular bone classification on the continuum between plates and rods. IEEE Trans Med Imaging (2010) 1.25

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 1.25

Quantitative assessment of bone tissue mineralization with polychromatic micro-computed tomography. Calcif Tissue Int (2008) 1.24

Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res (2008) 1.24

Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone (2007) 1.24

Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog (2012) 1.22

Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol (2009) 1.20

Deletion of the GATA domain of TRPS1 causes an absence of facial hair and provides new insights into the bone disorder in inherited tricho-rhino-phalangeal syndromes. Mol Cell Biol (2002) 1.20

Trabecular bone structure analysis in the limited spatial resolution regime of in vivo MRI. Acad Radiol (2008) 1.19

Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am J Pathol (2008) 1.19

Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL. Cancer Res (2010) 1.18

The effect of voxel size on high-resolution peripheral computed tomography measurements of trabecular and cortical bone microstructure. Med Phys (2012) 1.17

Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J Exp Med (2011) 1.16

A correlative method for imaging identical regions of samples by micro-CT, light microscopy, and electron microscopy: imaging adipose tissue in a model system. J Histochem Cytochem (2012) 1.15

Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res (2009) 1.14

High-resolution imaging techniques for the assessment of osteoporosis. Radiol Clin North Am (2010) 1.13

Three dimensional cancellous bone structure in hypoparathyroidism. Bone (2009) 1.12

Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2011) 1.11

Hierarchical microimaging of bone structure and function. Nat Rev Rheumatol (2009) 1.11

TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11

Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res (2008) 1.11

CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev (2010) 1.09

Micro computed tomography for vascular exploration. J Angiogenes Res (2010) 1.09

Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One (2009) 1.08

Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem (2011) 1.08

Role of trabecular microarchitecture in whole-vertebral body biomechanical behavior. J Bone Miner Res (2009) 1.08

Age-related changes in trabecular bone microstructures: global and local morphometry. Osteoporos Int (2005) 1.07

Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Miner Res (2008) 1.06

Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05

CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules. J Exp Med (2008) 1.05

Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A (2005) 1.04

Compressive axial mechanical properties of rat bone as functions of bone volume fraction, apparent density and micro-ct based mineral density. J Biomech (2009) 1.04

Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One (2009) 1.04

Microcomputed tomography-based structural analysis of various bone tissue regeneration models. Nat Protoc (2011) 1.03

Classification of trabeculae into three-dimensional rodlike and platelike structures via local inertial anisotropy. Med Phys (2009) 1.03

Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck. Osteoporos Int (2009) 1.02

Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. J Bone Miner Res (2010) 1.02

Substantial expression of mature elastin in arterial constructs. Proc Natl Acad Sci U S A (2011) 1.02

Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors. J R Soc Interface (2008) 1.01

Fabric dependence of wave propagation in anisotropic porous media. Biomech Model Mechanobiol (2010) 1.01

Assessment of trabecular bone structure using MDCT: comparison of 64- and 320-slice CT using HR-pQCT as the reference standard. Eur Radiol (2009) 0.99

Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models. Osteoporos Int (2008) 0.99

Pathogenesis of age-related osteoporosis: impaired mechano-responsiveness of bone is not the culprit. PLoS One (2008) 0.99

Accuracy of high-resolution in vivo micro magnetic resonance imaging for measurements of microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 0.99

Regional variations of vertebral trabecular bone microstructure with age and gender. Osteoporos Int (2008) 0.99

Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab (2013) 0.98

Implications of resolution and noise for in vivo micro-MRI of trabecular bone. Med Phys (2008) 0.97

Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia. PLoS One (2013) 0.96

Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome. Mol Pain (2012) 0.96

Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2012) 0.96

Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol Pharm (2011) 0.95

Fabric dependence of quasi-waves in anisotropic porous media. J Acoust Soc Am (2011) 0.95

Micro-CT and mechanical evaluation of subchondral trabecular bone structure between postmenopausal women with osteoarthritis and osteoporosis. Osteoporos Int (2009) 0.95

Shear strength behavior of human trabecular bone. J Biomech (2012) 0.95

Quantitative, structural, and image-based mechanical analysis of nonunion fracture repaired by genetically engineered mesenchymal stem cells. J Biomech (2010) 0.95

Side-artifact errors in yield strength and elastic modulus for human trabecular bone and their dependence on bone volume fraction and anatomic site. J Biomech (2007) 0.95

Trapezium trabecular morphology in carpometacarpal arthritis. J Hand Surg Am (2012) 0.94

Performance of the MRI-based virtual bone biopsy in the distal radius: serial reproducibility and reliability of structural and mechanical parameters in women representative of osteoporosis study populations. Bone (2011) 0.94

MicroCT morphometry analysis of mouse cancellous bone: intra- and inter-system reproducibility. Bone (2011) 0.94

Role of trabecular microarchitecture in the formation, accumulation, and morphology of microdamage in human cancellous bone. J Orthop Res (2011) 0.94

Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos Int (2013) 0.93

Dependence of mechanical properties of trabecular bone on plate-rod microstructure determined by individual trabecula segmentation (ITS). J Biomech (2013) 0.93

Alteration of femoral bone morphology and density in COX-2-/- mice. Bone (2006) 0.93

Articles by these authors

Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene (1995) 13.86

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99

Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res (1994) 10.72

Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73

Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem (1996) 5.42

Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44

Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc Natl Acad Sci U S A (1983) 4.38

The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J (1989) 4.27

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53

In vivo high resolution 3D-QCT of the human forearm. Technol Health Care (1998) 3.49

Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res (1986) 3.21

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16

Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res (1985) 3.09

A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int (1996) 2.98

Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. EMBO J (1989) 2.98

Ultrastructure of a periodic protein layer in the outer membrane of Escherichia coli. J Cell Biol (1977) 2.89

The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84

Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone (1999) 2.73

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila. EMBO J (1988) 2.70

Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J (1995) 2.67

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res (2001) 2.65

Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Biol (1998) 2.64

Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol (1971) 2.51

Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature (1985) 2.34

Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34

Camptodactyly in a painting by Dirk Bouts (c. 1410-1475). J R Soc Med (2004) 2.28

The structure of the RNA binding site of ribosomal proteins S8 and S15. J Biol Chem (1979) 2.24

Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology (1998) 2.24

Alternative splicing of human cyclin E. J Cell Sci (1994) 2.20

Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone (1998) 2.18

Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A (1985) 2.18

The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone (1999) 2.16

Inducible regulatory elements in the human cyclin D1 promoter. Oncogene (1994) 2.16

Justification of the 4-mmol/l lactate threshold. Int J Sports Med (1985) 2.15

The relationship between osteoporosis and osteoarthritis. Clin Rheum Dis (1985) 2.14

Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone (2002) 2.14

Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol (1983) 2.14

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis (1986) 2.13

KDR receptor: a key marker defining hematopoietic stem cells. Science (1999) 2.13

Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11

Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. EMBO J (1983) 2.08

Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08

Drug assay using antibody mimics made by molecular imprinting. Nature (1993) 2.04

Arthritis in Flemish paintings (1400-1700). Br Med J (1977) 2.03

Ridge number density: a new parameter for in vivo bone structure analysis. Bone (1997) 2.03

The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res (2001) 2.03

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02

Specificity and localization of the hepatitis B virus-associated protein kinase. J Virol (1982) 2.00

trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell (1989) 2.00

Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem (1985) 1.99

Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J (1990) 1.97

Revising the preventive paradox: the Swiss case. Addiction (2001) 1.92

Cell cycle regulation of E2F site occupation in vivo. Science (1996) 1.90

Chronic spinal pain syndromes: a clinical pilot trial comparing acupuncture, a nonsteroidal anti-inflammatory drug, and spinal manipulation. J Manipulative Physiol Ther (1999) 1.88

Effects of four Ni-Ti preparation techniques on root canal geometry assessed by micro computed tomography. Int Endod J (2001) 1.87

High prevalence and impact of rheumatic diseases is not reflected in the medical curriculum: the ILAR Undergraduate Medical Education in Rheumatology (UMER) 2000 project. Together everybody achieves more. International League of Associations for Rheumatology. J Rheumatol (1998) 1.85

Bone mass in osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am (1974) 1.85

How Renoir coped with rheumatoid arthritis. BMJ (1998) 1.84

An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation. EMBO J (1994) 1.83

Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell (1987) 1.83

Incorporation of [18O]water into 4-hydroxybenzoic acid in the reaction of 4-chlorobenzoate dehalogenase from pseudomonas spec. CBS 3. Biochem Biophys Res Commun (1984) 1.80

Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79

Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene (1994) 1.77

Purification and some properties of 2-halobenzoate 1,2-dioxygenase, a two-component enzyme system from Pseudomonas cepacia 2CBS. J Bacteriol (1992) 1.76

Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. Methods Enzymol (1983) 1.76

Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex. Nature (1989) 1.74

Molecular organization of the maternal effect region of the Shaker complex of Drosophila: characterization of an I(A) channel transcript with homology to vertebrate Na channel. EMBO J (1987) 1.74

Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J (1985) 1.73

Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene (1994) 1.73

Endothelial-like cells derived from human CD14 positive monocytes. Differentiation (2000) 1.73

Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71

Eutrophication causes speciation reversal in whitefish adaptive radiations. Nature (2012) 1.69

[Ampicillin--a semi-synthetic penicillin in pregnancy, the newborn and premature period]. Monatsschr Kinderheilkd (1968) 1.64

Multimodal imaging demonstrates concomitant changes in bone and cartilage after destabilisation of the medial meniscus and increased joint laxity. Osteoarthritis Cartilage (2010) 1.63

Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther (2001) 1.63

Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J (1984) 1.63

Rheumatoid lymphedema. J Rheumatol (1987) 1.62

Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone (1997) 1.62

Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion. EMBO J (1985) 1.60

Electromagnetic interference of pacemakers by mobile phones. Pacing Clin Electrophysiol (1996) 1.60

Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59

Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 A resolution. J Mol Biol (1987) 1.58

Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone (2004) 1.57

Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56

Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J (1995) 1.54

Chemical composition of the attachment pad secretion of the locust Locusta migratoria. Insect Biochem Mol Biol (2002) 1.54

Tissue and cell type-specific expression of two human c-onc genes. Nature (1983) 1.53

Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52

Regulation of c-fos transcription in mouse fibroblasts: identification of DNase I-hypersensitive sites and regulatory upstream sequences. EMBO J (1985) 1.51

The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51

Enzymatic dehalogenation of pentachlorophenol by extracts from Arthrobacter sp. strain ATCC 33790. J Bacteriol (1989) 1.50

Methotrexate osteopathy, does it exist? J Rheumatol (1996) 1.50

Comparison of structure extraction methods for in vivo trabecular bone measurements. Comput Med Imaging Graph (1999) 1.50

New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem (1999) 1.49

Human alpha2-macroglobulin: genotype-phenotype relation. Exp Neurol (2003) 1.47

Osteoporosis and osteoarthritis (osteoarthrosis). Anthropometric distinctions. JAMA (1983) 1.47